Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
0(0%)
Results Posted
50%(2 trials)
Terminated
1(17%)

Phase Distribution

Ph not_applicable
1
17%
Ph phase_1
2
33%
Ph phase_3
2
33%
Ph phase_4
1
17%

Phase Distribution

2

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
2(33.3%)
Phase 3Large-scale testing
2(33.3%)
Phase 4Post-market surveillance
1(16.7%)
N/ANon-phased studies
1(16.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

4 of 6 finished

Non-Completion Rate

33.3%

2 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Completed(4)
Terminated(2)

Detailed Status

Completed4
Terminated1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
80.0%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (33.3%)
Phase 32 (33.3%)
Phase 41 (16.7%)
N/A1 (16.7%)

Trials by Status

terminated117%
completed467%
withdrawn117%

Recent Activity

0 active trials
Showing 5 of 6
completedphase_3

Next-Day Residual Effects of Gabapentin, Diphenhydramine and Triazolam on Simulated Driving Performance in Normal Volunteers

NCT01888497
completedphase_4

Oral Versus Intravenous Sedation for Ocular Procedures

NCT03246724
terminatedphase_3

Pharmacovigilance in Gerontopsychiatric Patients

NCT02374567
completednot_applicable

Sensitivity of Project: EVO Monitor Cognitive Measurements to Pharmacological Agents

NCT02822937
withdrawnphase_1

Triazolam Trial In Healthy Subjects To Compare Bioavailability Between Formulations Of Triazolam To Determine Their Bioequivalence In Terms Of Rate And Magnitude Of Absorption

NCT01017926
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT01888497Phase 3

Next-Day Residual Effects of Gabapentin, Diphenhydramine and Triazolam on Simulated Driving Performance in Normal Volunteers

Completed
NCT03246724Phase 4

Oral Versus Intravenous Sedation for Ocular Procedures

Completed
NCT02374567Phase 3

Pharmacovigilance in Gerontopsychiatric Patients

Terminated
NCT02822937Not Applicable

Sensitivity of Project: EVO Monitor Cognitive Measurements to Pharmacological Agents

Completed
NCT01017926Phase 1

Triazolam Trial In Healthy Subjects To Compare Bioavailability Between Formulations Of Triazolam To Determine Their Bioequivalence In Terms Of Rate And Magnitude Of Absorption

Withdrawn
NCT01780259Phase 1

A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Intranasally Administered Esketamine in Healthy Participants

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6